King's College London

Funding Information: Dr Andre received financial support by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Dr Idiart and Dr Hidalgo from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Dr Kieling is a CNPq researcher and a UK Academy of Medical Sciences Newton Advanced Fellow. Dr Mondelli is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London and has received research funding from Johnson & Johnson, a pharmaceutical company interested in the development of anti-inflammatory strategies for depression, but the research described in this paper is unrelated to this funding. Dr Fisher is part supported by the Economic and Social Research Council (ESRC) Centre for Society and Mental Health at King’s College London [ES/S012567/1]. The IDEA project is funded by an MQ Brighter Futures grant [MQBF/1 IDEA]. Additional support was provided by the UK Medical Research Council [MC_PC_MR/R019460/1] and the Academy of Medical Sciences [GCRFNG\100281] under the Global Challenges Research Fund. BAK received support from the US National Institute of Mental Health [K01MH104310, R21MH111280].We are also grateful to all members of the IDEA team for their dedication and hard work. We are grateful to the team of Laboratório de Cronobiologia e Sono HCPA/UFRGS, especially Ana Abreu, Melissa de Oliveira and Nicóli Xavier, for the insightful input to this project and to other projects in this research line. Publisher Copyright: © 2022 Taylor & Francis Group, LLC.